BIOA · Forms 3, 4, 5
Insider trades at BioAge Labs, Inc.
No open-market insider buys or sells at BioAge Labs, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for BioAge Labs, Inc. (BIOA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for BioAge Labs, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Shane Barton | Principal Accounting Officer | Option exercise | 4,290 | $10.85 | $47K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Option exercise | 4,000 | $8.39 | $34K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Option exercise | 4,065 | $4.30 | $17K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Option exercise | 7,861 | $4.38 | $34K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Sell (10b5-1 plan) | 20,216 | $25.19 | $509K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Option exercise | 9,301 | $10.85 | $101K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Option exercise | 7,261 | $8.39 | $61K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Option exercise | 8,958 | $4.30 | $39K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Option exercise | 14,198 | $4.38 | $62K | Form 4 | |
| Shane Barton | Principal Accounting Officer | Sell (10b5-1 plan) | 42,350 | $25.21 | $1.1M | Form 4 | |
| Vijay Satyanand Pande | Director | Options or other derivatives | Form 4 | ||||
| Rekha Hemrajani | Director | Options or other derivatives | Form 4 | ||||
| James Healy | Director | Options or other derivatives | Form 4 | ||||
| Patrick G Enright | Director | Options or other derivatives | Form 4 | ||||
| Michael H. Davidson | Director | Options or other derivatives | Form 4 | ||||
| Jean Pierre Garnier | Director | Options or other derivatives | Form 4 | ||||
| Dov A Md Goldstein | Chief Financial Officer | Option exercise | 3,542 | $4.38 | $16K | Form 4 | |
| Paul D Rubin | Chief Medical Officer | Option exercise | 5,437 | $4.11 | $22K | Form 4 | |
| Paul D Rubin | Chief Medical Officer | Option exercise | 3,383 | $6.57 | $22K | Form 4 | |
| Paul D Rubin | Chief Medical Officer | Sell (10b5-1 plan) | 8,820 | $17.81 | $157K | Form 4 | |
| Paul D Rubin | Chief Medical Officer | Option exercise | 5,433 | $4.11 | $22K | Form 4 | |
| Paul D Rubin | Chief Medical Officer | Option exercise | 2,000 | $6.57 | $13K | Form 4 | |
| Paul D Rubin | Chief Medical Officer | Sell (10b5-1 plan) | 7,433 | $20.30 | $151K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.